UK authorises world’s first Covid-19 vaccine, Pfizer/BioNTech’s BNT162b2
Just nine months since the Covid-19 pandemic began, the first vaccine to prevent this deadly viral disease has been approved.…
02 Dec 2020
UK grants authorisation to Pfizer, BioNTech’s Covid-19 vaccine
The Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK has granted a temporary authorisation for emergency use to Pfizer and its German partner BioNTech’s mRNA vaccine, BNT162b2, for…
02 Dec 2020
EMA initiates rolling review of Janssen’s Covid-19 vaccine candidate
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has initiated a rolling review of Janssen and Cilag International’s Covid-19 vaccine candidate, Ad26.COV2.S. The vaccine candidate…
01 Dec 2020
Moderna reports 100% vaccine efficacy against severe Covid-19
Moderna has announced that the primary efficacy analysis data from the Phase III COVE study of mRNA-1273 indicated 100% vaccine efficacy against severe Covid-19. The study conducted on 196 cases…
30 Nov 2020
RDIF, Hetero agree for 100 million Sputnik V vaccine doses production in India
The Russian Direct Investment Fund (RDIF) and Indian generic pharma firm Hetero, through its biologics arm Hetero Biopharma, have agreed to annually produce more than 100 million doses of Covid-19…
30 Nov 2020
Special delivery: the logistics of curing Covid-19
When it comes to the Covid-19 pandemic, a vaccine remains the holy grail. Once a vaccine is released, the most vulnerable in society can be protected and some form of…
30 Nov 2020
Moderna and UK sign deal to supply two million more Covid-19 vaccine doses
Moderna has signed an agreement with the UK Government to supply an additional two million doses of its Covid-19 vaccine candidate, mRNA-1273, from March next year. With this deal, the…